v3.26.1
Operating costs
12 Months Ended
Dec. 31, 2025
Operating costs  
Operating costs

17. Operating costs

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023*

Staff costs (note 18)

 

389,230

242,591

238,527

Depreciation (notes 8/9)

 

8,472

192,698

11,752

External research and development costs

 

190,190

435,189

942,714

Patent maintenance and registration costs

 

188,918

283,382

229,227

Professional fees

 

1,314,859

1,206,813

1,163,839

D&O insurance

183,841

225,772

628,595

Fair value of services received at zero costs (note 10)

141,018

Other operating costs

 

570,930

578,830

645,501

Total operating costs

 

2,987,458

3,165,275

3,860,155

The evolution of the total operating costs is mainly driven by external research and development expenses, staff costs, D&O insurance, professional fees and other operating costs.

During the twelve-month period ended December 31, 2025, total operating costs recognized as continuing operations decreased by CHF 0.2 million compared to the same period ended December 31, 2024, primarily due to decreased external research and development cost, lower D&O insurance and patent maintenance and registration costs, partially offset by increased staff costs and professional fees and other operating costs.

During the twelve-month period ended December 31, 2024, total operating costs recognized as continuing operations decreased by CHF 0.7 million compared to the year ended December 31, 2023, primarily due to decreased external research and development cost of CHF 0.5 million and lower D&O insurance of CHF 0.4 million, partially offset by increased depreciation of CHF 0.2 million related to the intangible asset recorded at the fair value of the service agreement provided at zero cost (note 10).

During the twelve-month periods ended December 31, 2023 and 2024, total operating costs recognized as discontinued operations amounted to CHF 8.1 million and CHF 2.0 million respectively and primarily related to staff costs and external research and development costs (note 22).